CONMED Corporation  

(Public, NASDAQ:CNMD)   Watch this stock  
Find more results for Robert R. Bent
-0.01 (-0.02%)
Real-time:   12:03PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 44.08 - 46.00
52 week 35.85 - 50.47
Open 44.75
Vol / Avg. 58,602.00/128,765.00
Mkt cap 1.23B
P/E 40.23
Div/yield 0.20/1.78
EPS 1.11
Shares 27.53M
Beta 1.45
Inst. own 94%
Feb 11, 2015
Q4 2014 Conmed Corp Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Jan 14, 2015
Conmed Corp at JPMorgan Healthcare Conference - 11:30AM EST - Add to calendar
Dec 2, 2014
CONMED at 26th Annual Piper Jaffray Healthcare Conference - Webcast
Oct 23, 2014
Q3 2014 Conmed Corp Earnings Call - Webcast
Oct 23, 2014
Q3 2014 Conmed Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 1.13% 4.71%
Operating margin 1.40% 7.37%
EBITD margin - 15.71%
Return on average assets 0.72% 3.31%
Return on average equity 1.32% 5.92%
Employees 3,600 -
CDP Score - -


UTICA, NY 13502
United States - Map
+1-315-6243215 (Phone)
+1-315-7970321 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


CONMED Corporation (CONMED) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The Company operates in five segments: CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care. The Company offers a range of devices and products for uses in arthroscopic surgery. The Company's powered instruments product line includes the MPower battery system. The Company's patient care product line includes a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, electrocardiogram (ECG) electrodes and cables, cardiac defibrillation and pacing pads and blood pressure cuffs.

Officers and directors

Mark E. Tryniski Independent Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Curt R. Hartman President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Robert D. Shallish Jr. Chief Financial Officer, Executive Vice President - Finance
Age: 65
Bio & Compensation  - Reuters
Daniel S. Jonas Executive Vice President - Legal Affairs, General Counsel
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Luke A. Pomilio Chief Financial Officer, Executive Vice President - Finance
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Heather L. Cohen Executive Vice President - Human Resources, Deputy General Counsel, Secretary
Age: 41
Bio & Compensation  - Reuters
Joseph G. Darling Executive Vice President - Commercial Operations
Age: 56
Bio & Compensation  - Reuters
Gregory Renard Jones Executive Vice President - Quality Assurance/Regulatory Affairs
Age: 59
Bio & Compensation  - Reuters
Brian P. Concannon Independent Director
Age: 56
Bio & Compensation  - Reuters
Charles Farkas Independent Director
Bio & Compensation  - Reuters